Remberger M - Search Results

1

Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation.

Hägglund H, Remberger M, Klaesson S, Lönnqvist B, Ljungman P, Ringdén O. Hägglund H, et al. Among authors: remberger m. Blood. 1998 Dec 15;92(12):4568-72. Blood. 1998. PMID: 9845522 Free article.

2

Cytokines in fetal blood and amniotic fluid in Rh-immunized pregnancies.

Westgren M, Ek S, Remberger M, Ringden O, Stangenberg M. Westgren M, et al. Among authors: remberger m. Obstet Gynecol. 1995 Aug;86(2):209-13. doi: 10.1016/0029-7844(95)00132-b. Obstet Gynecol. 1995. PMID: 7542377

3

Ringdén O, Remberger M, Persson U, Ljungman P, Aldener A, Andström E, Aschan J, Bolme P, Dahllöf G, Dalianis T, et al. Ringdén O, et al. Among authors: remberger m. Bone Marrow Transplant. 1995 Apr;15(4):619-25. Bone Marrow Transplant. 1995. PMID: 7655390

4

Safety of liposomal amphotericin B (AmBisome) in 187 transplant recipients treated with cyclosporin.

Ringdén O, Andström E, Remberger M, Svahn BM, Tollemar J. Ringdén O, et al. Among authors: remberger m. Bone Marrow Transplant. 1994;14 Suppl 5:S10-4. Bone Marrow Transplant. 1994. PMID: 7703925

5

TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD.

Remberger M, Ringden O, Markling L. Remberger M, et al. Bone Marrow Transplant. 1995 Jan;15(1):99-104. Bone Marrow Transplant. 1995. PMID: 7742764

6

Allergic reactions and other rare side-effects of liposomal amphotericin.

Ringdén O, Andström E, Remberger M, Svahn BM, Tollemar J. Ringdén O, et al. Among authors: remberger m. Lancet. 1994 Oct 22;344(8930):1156-7. doi: 10.1016/s0140-6736(94)90663-7. Lancet. 1994. PMID: 7934512 No abstract available.

7

Long-term follow-up of a randomized trial comparing T cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.

Ringdén O, Remberger M, Aschan J, Lungman P, Lönnqvist B, Markling L. Ringdén O, et al. Among authors: remberger m. Transplantation. 1994 Oct 27;58(8):887-91. doi: 10.1097/00007890-199410270-00005. Transplantation. 1994. PMID: 7940731 Clinical Trial.

8

Individualized prophylaxis against graft-versus-host disease in leukemic marrow transplant recipients.

Aschan J, Ringdén O, Andström E, Ljungman P, Lönnqvist B, Remberger M. Aschan J, et al. Among authors: remberger m. Bone Marrow Transplant. 1994 Jul;14(1):79-87. Bone Marrow Transplant. 1994. PMID: 7951124 Clinical Trial.

9

Risk factors for acute graft-versus-host disease in 325 consecutive bone marrow recipients.

Hägglund H, Boström L, Ringdén O, Nilsson B, Remberger M. Hägglund H, et al. Among authors: remberger m. Transplant Proc. 1994 Jun;26(3):1821-2. Transplant Proc. 1994. PMID: 8030154 No abstract available.

10

Prevention of graft-versus-host disease on an individual basis.

Aschan J, Ringdén O, Andström E, Ljungman P, Remberger M. Aschan J, et al. Among authors: remberger m. Transplant Proc. 1994 Jun;26(3):1823-4. Transplant Proc. 1994. PMID: 8030155 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters